Jack Health Review: Pricing, Safety & Personalization

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Jack Health is a telemedicine platform offering subscription-based access to GLP-1 receptor agonists for weight management and metabolic support. The service combines virtual provider consultations with home delivery, typically ranging from $99 to $349 per month depending on medication and dose. Understanding how Jack Health's model compares to other precision-wellness approaches—including genetic assessment of peptide pathways—helps patients make informed decisions.

Selecting a GLP-1 treatment involves more than pricing; it requires alignment between provider expertise, medication formulation, and individual metabolic factors. PlexusDx emphasizes precision-wellness through biomarker context and optional genetic predisposition testing, enabling more informed conversations with qualified providers about which compounded GLP-1 option may be right for you.

How Jack Health's Telemedicine Model Works

Jack Health operates through an asynchronous video consultation followed by prescription shipment to your home. Initial consultations assess weight history, comorbidities, and medication use. Providers then recommend a medication and starting dose, with medication shipped within days. Monthly costs include the provider consultation fee plus the medication itself.

Unlike in-person clinics, Jack Health relies on questionnaires and video assessment rather than in-office labs or biomarker testing. This streamlined model reduces administrative burden but may limit tailored dosing strategies that could benefit from baseline metabolic markers or genetic predisposition data.

Jack Health Pricing and Medication Options Compared

Jack Health primarily offers semaglutide and tirzepatide through partnerships with fulfillment services. Pricing varies by medication strength, refill frequency, and package add-ons. This comparison framework illustrates how Jack Health's costs align with alternative compounded GLP-1 access points, including PlexusDx offerings from licensed 503A pharmacies.

Factor	Jack Health Typical Pricing	PlexusDx Compounded Options
Semaglutide Injection Monthly	$129–$249 (varies by dose)	$149 from licensed 503A pharmacies
Tirzepatide Injection Monthly	$199–$349 (varies by dose)	$249 from licensed 503A pharmacies
Oral Semaglutide	Not typically offered	$249/mo from licensed 503A pharmacies
Microdose GLP-1 Protocol	Not available	$129/month (precision low-dose option)
Initial Consultation & Assessment	Usually $99–$199 included	Provider consultation variable; genetic test $99 add-on or $298 standalone

The Role of Genetic Predispositions in GLP-1 Selection

Recent research suggests that genetic variations in GLP-1 receptor (GLP1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and appetite-regulation genes (FTO, MC4R) may correlate with individual response patterns to GLP-1 therapy. These genetic predispositions do not determine medication response but may help provide context for provider conversations about dose initiation and titration strategy.

PlexusDx offers the Precision Peptide Genetic Test, which examines key variants (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) to reveal predispositions in peptide pathways. This test should be interpreted with a qualified provider and complements rather than replaces clinical assessment. Jack Health does not routinely include genetic testing in its standard model.

Compounded vs. Branded GLP-1 Access: What Patients Should Know

Jack Health may dispense branded semaglutide (Ozempic/Wegovy equivalent) or tirzepatide (Mounjaro equivalent) depending on their pharmacy partnerships and insurance coverage. Compounded medications from licensed 503A pharmacies (PlexusDx offerings) are formulated by state-licensed pharmacists and typically cost 20–40% less than branded options while maintaining quality standards.

A critical distinction: compounded GLP-1 medications are not FDA-approved as branded drugs, but 503A compounding pharmacies operate under state pharmacy law and FDA oversight. Patients should confirm pharmacy licensure and verify that compounded options meet their insurance and provider requirements before starting treatment.

Safety Considerations and Provider Guidance

GLP-1 receptor agonists carry known risks including nausea, pancreatitis, and rare thyroid concerns. Jack Health's telemedicine model screens for contraindications via questionnaire; however, some patients benefit from baseline labs (lipid panel, liver function, fasting glucose) before initiation. PlexusDx recommends discussing baseline biomarker assessment with your provider regardless of platform choice.

Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not use GLP-1 drugs. Pregnancy, severe kidney disease, and certain gastrointestinal conditions also warrant careful provider evaluation. Both telemedicine and in-person providers must conduct thorough eligibility screening before prescribing.

How PlexusDx Supports a More Personalized Approach

PlexusDx's approach to GLP-1 selection emphasizes biomarker and genetic context alongside medication formulation. The Precision Peptide Genetic Test may help provide context by revealing predispositions in key GLP-1 pathway genes; this information should be interpreted with a qualified healthcare provider to support more personalized medication and dosing conversations. Genetic predispositions indicate potential response patterns but do not predict exact medication efficacy or side-effect risk.

The Precision Peptide Genetic Test examines GLP1R, GIPR, FTO, and MC4R variants to offer insight into individual peptide-pathway predispositions. When combined with clinical assessment, baseline metabolic markers, and provider judgment, this test may help inform whether a standard-dose, microdose, or dual-compound protocol (such as PlexusDx GLP-Squared) aligns best with your metabolic profile. No genetic test replaces medical evaluation.

Whether you choose Jack Health, PlexusDx compounded options, or another telemedicine provider, integrating genetic and biomarker insight into your provider discussion can support more informed treatment selection. Ask your provider about baseline labs, discuss any family history of metabolic or thyroid conditions, and clarify whether genetic testing aligns with your treatment goals before starting.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Jack Health a legitimate and FDA-regulated service?

Jack Health operates as a licensed telemedicine provider and partners with state-regulated pharmacies. However, telemedicine GLP-1 services are not themselves FDA-regulated; the medications they dispense are. Verify that Jack Health's pharmacy partners hold active state licenses and meet your insurance requirements.

How does Jack Health pricing compare to in-person clinics?

Jack Health's subscription model ($99–$349/month) is typically comparable to or slightly lower than in-person clinic fees plus medication costs. Compounded GLP-1 from licensed 503A pharmacies (PlexusDx range $129–$309/month) may offer additional cost savings depending on dose and medication type.

Can genetic testing help determine which GLP-1 medication I should use?

Genetic predispositions in peptide pathways may provide context for provider conversations about medication selection and dosing strategy. PlexusDx Precision Peptide Genetic Test examines GLP1R, GIPR, FTO, and MC4R variants. However, genetics do not predict exact medication response and should be interpreted with your healthcare provider alongsi...

What's the difference between compounded semaglutide and branded Wegovy?

Compounded semaglutide (from licensed 503A pharmacies) and branded Wegovy contain the same active ingredient but differ in formulation, manufacturing oversight, and cost. Compounded options are not FDA-approved as branded drugs but are legally dispensed under state pharmacy law and FDA oversight.

Should I get baseline lab work before starting a GLP-1 medication?

Yes, baseline labs including fasting glucose, lipid panel, liver function, and kidney function support informed provider decision-making. While telemedicine platforms like Jack Health may screen by questionnaire, in-person or hybrid models that include baseline biomarkers may better personalize dosing and monitor safety.

Jack Health Review: Genetic Testing and Personalized GLP-1 Options